Eliem Therapeutics

BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Flag link:
Eliem drops depression drug, ending pursuit of Biogen-Sage and laying off 55% of team
Eliem drops depression drug, ending pursuit of Biogen-Sage and laying off 55% of team
Fierce Biotech
Eliem Therapeutics
depression
layoffs
ETX-155
Flag link:
Drug makers leave the pain behind
Drug makers leave the pain behind
EP Vantage
painkillers
Acadia
Eli Lilly
Ampio Pharmaceuticals
Aptinyx
Eliem Therapeutics
Vertanical
Teva Pharamceutical
Regeneron
Vivozon
Vertex Pharmaceuticals
Biogen
Flag link:
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
Sometimes, Clinical Trials Miss the Mark: Neurocrine, Akebia, Eliem and Athira
BioSpace
clinical trials
Neurocrine Biosciences
Akebia Therapeutics
Eliem Therapeutics
Athira Pharma
Flag link:
IPOs continue to bustle as three more biotechs prepare to make the Nasdaq leap
IPOs continue to bustle as three more biotechs prepare to make the Nasdaq leap
Endpoints
IPOs
Adagio Therapeutics
Castle Creek Biosciences
Eliem Therapeutics
Flag link:
Eliem raises $60M to take neuro programs to series of data drops
Eliem raises $60M to take neuro programs to series of data drops
Fierce Biotech
Eliem Therapeutics
funding
neuronal excitability disorders
neurology
Flag link:
Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
Eliem exits stealth with $80M to run midphase pain trials, advance pipeline of neuro programs
Fierce Biotech
Eliem Therapeutics
chronic pain
clinical trials
PEA
Flag link: